A Clinical Efficacy Study of MsChief Personal Lubricant in Healthy Female Subjects

NCT ID: NCT05738733

Last Updated: 2023-07-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

138 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-02

Study Completion Date

2023-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A Proof of Science, Open-Label, Single Centre, Four-Arm, In-Use Tolerance, Safety, and Efficacy Clinical Study of MsChief Personal Lubricant in Healthy Female Subjects.

30 subjects/product (33 subjects' enrolment/treatment) healthy non-pregnant/non-lactating females with an age of 18 - 65 years old.

A total of up to 132 subjects (33 subjects/product) will be enrolled to get 120 completed subjects (30 subjects/product) in the study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A sufficient number of healthy female subjects with an age group of 18 - 65 years old with a Nugent score ≤3 will be recruited/enrolled.

The potential subjects will be screened as per the inclusion \& exclusion criteria only after obtaining written informed consent from the subjects. The subjects will be instructed to visit the facility as per the below visits

* Visit 01 (Within 07 Days): Screening, Baseline evaluations
* Visit 02 (Day 01): Enrolment \& Test Products usage phase start
* Visit 03 (Day 16): Test Products usage ends, End of the study Subjects will be pre-screened by the screening department of NovoBliss Research. Subjects will be telephonically contacted by recruiting department prior to the enrolment visit. Subjects will be instructed during screening (prior to enrolment) not to use any other product for intimate washes, lubricant, or any other product during the study.

Assessment of efficacy parameters will be done before test products usage on Day 1 and will be compared with after test products usage during Day 16 as listed below.

1. Gynaecological Assessments

* Local irritation, pruritus, erythema, edema
* Moisturizing effect - moisture, dryness, flaking, epithelial mucosa
* Quality and odour of vaginal discharge
* Vaginal pH measure using pH paper
* Clinical symptoms associated with infections
* Verbal rating scale (0-4 score)- Vaginal itching
2. Subjective Self-assessments

* Perceived irritations - Burning, Itching, Stinging, Discomfort
* Sexual activity (where appropriate)
* VAS Scoring for Vaginal itchiness
* Quality of life assessment
3. Microbiological Assessments • Nugents scoring

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Females

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A proof-of-science, open-label, single-centre, four-arm, In-Use tolerance, safety, efficacy clinical study
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

The study is open-label.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MsChief Classic Natural Lubricant

MsChief Classic natural lubricant contains aqua, propylene glycol, hydroxyethyl cellulose, ethyl menthane carboxamide and methyl diisopropyl propionamide, aloe barbadensis leaf juice, benzoic acid, hippophae Rhamnoides extract, tocophersolan, sodium hydroxide. MsChief Classic natural lubricant is a special moisturizer with aloe vera, vitamin E and sea buckthorn. It not only conditions but also moisturises the skin. This lubricant is water-based is free of sugar or saccharine. This product does not contain paraben or glycerine. This product has a unique formulation pH ideal for intimate area.

Group Type EXPERIMENTAL

MsChief Classic Natural Lubricant

Intervention Type DEVICE

Apply the desire amount of lubricant on the body to make it more sensitive.

MsChief Ylang Ylang Natural Lubricant

MsChief Ylang Ylang natural lubricant contains aqua, propylene glycol, flavour, hydroxyethyl cellulose, ethyl menthane carboxamide and methyl diisopropyl propionamide, aloe barbadensis leaf juice, benzoic acid, hippophae Rhamnoides extract, tocophersolan, sodium hydroxide. MsChief Ylang Ylang natural lubricant is a special moisturizer with aloe vera, vitamin E and sea buckthorn It not only conditions but also moisturise the skin. This lubricant is water-based contain natural flavour and free of sugar or saccharine. This product does not contain paraben or glycerine. This product has a unique formulation pH ideal for intimate area.

Group Type EXPERIMENTAL

MsChief Ylang Ylang Natural Lubricant

Intervention Type DEVICE

Apply the desire amount of lubricant on the body to make it more sensitive.

MsChief Vanilla & Citrus Natural Lubricant

MsChief vanilla and citrus natural lubricant contain aqua, propylene glycol, flavour, hydroxyethyl cellulose, ethyl menthane carboxamide and methyl diisopropyl propionamide, aloe barbadensis leaf juice, benzoic acid, hippophae Rhamnoides extract, tocophersolan, sodium hydroxide. MsChief vanilla and citrus natural lubricant is a special moisturizer with Aloe vera, vitamin E and sea buckthorn. It not only conditions but also moisturise the skin. This lubricant is water based contain natural flavour and free of sugar or saccharine. This product does not contain paraben or glycerine. This product has a unique formulation pH ideal for intimate area.

Group Type EXPERIMENTAL

MsChief Vanilla & Citrus Natural Lubricant

Intervention Type DEVICE

Apply the desire amount of lubricant on the body to make it more sensitive.

MsChief Tea & Peach Natural Lubricant

MsChief tea \& peach natural lubricant contains aqua, propylene glycol, flavour, hydroxyethyl cellulose, ethyl menthane carboxamide and methyl diisopropyl propionamide, aloe barbadensis leaf juice, benzoic acid, hippophae Rhamnoides extract, tocophersolan, sodium hydroxide. MsChief tea \& peach natural lubricant is a special moisturizer with Aloe vera, vitamin E and sea buckthorn. It not only conditions but also moisturises the skin. This lubricant is water-based contains natural flavour and is free of sugar or saccharine. This product does not contain paraben or glycerine. This product has a unique formulation pH ideal for intimate area.

Group Type EXPERIMENTAL

MsChief Tea & Peach Natural Lubricant

Intervention Type DEVICE

Apply the desire amount of lubricant on the body to make it more sensitive.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MsChief Classic Natural Lubricant

Apply the desire amount of lubricant on the body to make it more sensitive.

Intervention Type DEVICE

MsChief Ylang Ylang Natural Lubricant

Apply the desire amount of lubricant on the body to make it more sensitive.

Intervention Type DEVICE

MsChief Vanilla & Citrus Natural Lubricant

Apply the desire amount of lubricant on the body to make it more sensitive.

Intervention Type DEVICE

MsChief Tea & Peach Natural Lubricant

Apply the desire amount of lubricant on the body to make it more sensitive.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age: 18 to 65 years (both inclusive) at the time of consent.
2. Sex: Healthy non-pregnant/non-lactating females

* Females of fertile reproductive age with a propensity to vulvo-vaginal infection (18 years to 40 years)
* Females in the pre-menopausal age group (41 years to 48 years)
* Females in the post-menopausal age group (49 years to 65 years)
3. The subject is with Nugent score ≤3.
4. The subject with an active sex life of at least 01 sexual intercourse in a week
5. The subject of childbearing potential must have a reported negative pregnancy during screening and the end of the study.
6. The subject without a history of sensitivity to similar products/formulations
7. The subject is willing to give written informed consent and is willing to follow the study procedures.
8. The subject is willing to abide by the study protocol and study restrictions including abstinence from the use of any other product besides the test product for intimate wash, lubricant or any other products during the study.
9. The subject is a personal lubricant user and agrees to replace her usual personal lubricant with the test product.
10. The subject of childbearing potential who is willing to use a highly effective method of contraception throughout the clinical investigation.
11. The subject is of childbearing potential, is practising and agrees to maintain an established method of birth control (IUD, hormonal implant device/injection, regular use of birth control pills or patch, diaphragm, condoms, partner vasectomy or abstinence). Females will be considered as non-childbearing potential if they are surgically sterile, have been post-menopausal for at least 1 year or have had a tubal ligation.
12. If currently using hormonal contraception, has been using this form of contraception for at least 6 months and agrees to continue using the same contraception for the duration of the study.
13. The subject who agrees to have a gynaecological pelvic examination to ensure no significant disease findings and have intact skin and mucous in the test region assessed by the gynaecologist at all the relevant time points

Exclusion Criteria

1. The subject used other intra-vaginal gel moisturizers during the study.
2. The subject with Nugent score \>3.
3. The subject who is diagnosed with cancer
4. The subject using hormone replacement therapy for the last 3 months
5. The subject has a history or visible evidence of chronic skin disease or regional infections, genital herpes, vaginal infections or urinary tract infections.
6. Pregnant or lactating, women who are likely to become pregnant.
7. The subject exhibits or reports gynecologic abnormalities or has had vaginitis within 60 days prior to study initiation.
8. Personal history of allergy and hypersensitivity to any product of feminine hygiene, severe systemic complications of viral infections, severe systemic illness like cardiovascular disorders, neurological disorders, renal disorders, and autoimmune disorders.
9. The subject with any form of chronic infection/ allergy/ disease which may influence the study result
10. The subject with bacterial vaginosis/candidiasis/mycotic infections
11. The subject participated in clinical studies or had received any investigational agent in the previous 30 days.
12. The subject is not willing to sign an informed consent form.
13. The subject is an employee at the site or a partner or first-degree relative of the Investigator.
14. The subject fails to satisfy the Investigator of fitness to participate for any other reason.
15. The subject has had previous episodes of vaginal bleeding of unknown origin within the last 6 months of the screening visit.
16. The subject showed vaginal prolapse and/or other medical conditions that could interfere with the study's conduct and participation.
17. The subject who has used any kind of systemic and/or local hormonal products for vaginal dryness or any other vaginal condition in the 3 months prior to screening
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

TTK Healthcare Ltd - Protective Devices Division

UNKNOWN

Sponsor Role collaborator

NovoBliss Research Pvt Ltd

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr Nayan Patel

Principal Investigator - Medical Director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dr Nayan K Patel, MBBS

Role: PRINCIPAL_INVESTIGATOR

Medical Director

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Krisha Hospital

Gandhinagar, Gujarat, India

Site Status

Countries

Review the countries where the study has at least one active or historical site.

India

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NB230002-TT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Postcoital Testing of the SILCS Diaphragm
NCT00561613 COMPLETED PHASE1